.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Novartis
Harvard Business School
Cipla
Argus Health
QuintilesIMS
Boehringer Ingelheim
Teva
Colorcon
Mallinckrodt

Generated: November 23, 2017

DrugPatentWatch Database Preview

Fera Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for FERA PHARMS, and what generic and branded alternatives to FERA PHARMS drugs are available?

FERA PHARMS has four approved drugs.



Summary for Fera Pharms

US Patents:0
Tradenames:4
Ingredients:4
NDAs:4
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fera Pharms Llc
LEVOTHYROXINE SODIUM
levothyroxine sodium
POWDER;INTRAVENOUS206163-001Jun 29, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Fera Pharms
HYDROCORTISONE ACETATE
hydrocortisone acetate
OINTMENT;OPHTHALMIC080828-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Fera Pharms
DAPIPRAZOLE HYDROCHLORIDE
dapiprazole hydrochloride
SOLUTION/DROPS;OPHTHALMIC019849-001Dec 31, 1990DISCNYesNo► Subscribe► Subscribe► Subscribe
Fera Pharms
TOBRAMYCIN
tobramycin
SOLUTION/DROPS;OPHTHALMIC065026-001Sep 11, 2001ATRXNoNo► Subscribe► Subscribe► Subscribe
Fera Pharms Llc
LEVOTHYROXINE SODIUM
levothyroxine sodium
POWDER;INTRAVENOUS206163-002Jun 29, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Fera Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fera Pharms
DAPIPRAZOLE HYDROCHLORIDE
dapiprazole hydrochloride
SOLUTION/DROPS;OPHTHALMIC019849-001Dec 31, 1990► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for FERA PHARMS drugs

Drugname Dosage Strength Tradename Submissiondate
levothyroxine sodium
for Injection200 mcg/vial
LEVOTHYROXINE SODIUM
5/1/2015
levothyroxine sodium
for Injection100 mcg/vial and 500 mcg/vial
LEVOTHYROXINE SODIUM
4/14/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Teva
Boehringer Ingelheim
Cantor Fitzgerald
Dow
Fish and Richardson
US Army
McKinsey
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot